Answers are grounded in this paper and cite their sources.
Reports of HCV transmission from three HCV NAT-negative donors provide important insight into the understanding of the limits of donor testing, the need to refine current definitions of increased risk donors, and how essential it is to perform early posttransplant screening on recipients of organs from donors with a recognized risk of disease transmission. See article by Suryaprasad et al on page 1827.
No takes yet. Share an insight, caveat, or question.
Michael G. Ison (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: